BioBridgeXAll companies

C4 Therapeutics, Inc.

Biotechnology company · Watertown, Massachusetts, United States · Nasdaq: CCCC

C4 Therapeutics, Inc. is a biotechnology company headquartered in Watertown, Massachusetts, United States. Its earliest recorded incorporation is in 2015. Its shares trade on Nasdaq under the ticker CCCC. It has reported private securities offerings to the US SEC, most recently $70 million sold in a notice filed in 2016.

Profile compiled from public records. Is this your company? Request a correction or update

C4 Therapeutics at a glance

Typebiotechnology company
HeadquartersWatertown, Massachusetts, United States
Earliest incorporation on record2015
Stock listingNasdaq: CCCC
SEC industryBiological Products, (No Diagnostic Substances)
SEC CIK1662579

What does C4 Therapeutics do?

Private fundraising reported to the SEC

1 Form D notice; the most recent reported $70.3 million sold (2016).

Frequently asked questions about C4 Therapeutics

Where is C4 Therapeutics headquartered?

C4 Therapeutics, Inc. is headquartered in Watertown, Massachusetts, United States.

What does C4 Therapeutics do?

C4 Therapeutics, Inc. is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).

Is C4 Therapeutics a public company?

Yes. C4 Therapeutics, Inc. trades on Nasdaq under the ticker CCCC.

When was C4 Therapeutics founded?

The earliest incorporation on record for C4 Therapeutics, Inc. is in 2015, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences